- About Us
- Research Team
Considered a pioneer in the field of Parkinson’s and related neurodegenerative diseases and the recipient of 8 regional and international awards recognizing his scientific and leadership contributions, Dr. Omar El-Agnaf has demonstrated equal adeptness at directing QBRI’s efforts to improve and transform healthcare through innovations in prevention, diagnosis, and treatment of diseases affecting Qatar and the region. Since being appointed Acting Executive Director in 2016, QBRI has realized significant achievements under his direction. From securing extramural research funding from national and international funding agencies to establishing robust alliances with biotechnology and pharmaceutical companies to winning the 2017 Arab Best Research Institution of the Year Award, QBRI has excelled because of Dr. El-Agnaf’s leadership.
Over the past 20 years, Dr. El-Agnaf’s research group has built a reputable portfolio in the Middle East and beyond, placing his lab at the forefront of neuroscience research internationally. His discoveries have greatly impacted the scientific research community, provided further insight into the molecular pathogenesis of Parkinson’s disease, and offered new opportunities for the development of novel diagnostic and therapeutic tools for the disease.
With this same level of dedication and commitment, he has made significant strides in creating an innovative, forward-thinking, and supportive research environment at QBRI. Dr. El-Agnaf’s scientific contributions have been well received by many prestigious international funding agencies and pharmaceutical companies, resulting in millions of dollars of funding. Moreover, he is frequently invited as a speaker at international scientific and clinical meetings and is currently a member of the editorial boards of several international journals. Publications in high-ranking scientific journals validate Dr. El-Agnaf's track record of superior basic and translational research productivity. He has published nearly 120 refereed articles, with citations exceeding 9,000 (to date), and possesses an h-index of 52.
As the recipient of 6 patents, with an additional six under consideration, and possessing notable experience in licensing products stemming from his novel research, Dr. El-Agnaf understands how such activities can be used effectively to facilitate successful innovation. As such, he has prioritized the implementation of an executable innovation and commercialization plan across QBRI’s research projects as a primary objective.
Dr. El-Agnaf has been instrumental in guiding QBRI’s efforts to become a more fully evolved and productive space for its researchers to effectively achieve their potential.
QBRI is currently looking to recruit highly-skilled individuals for a number of roles.
Adamcik J, Sánchez-Ferrer A, Ait-Bouziad N, Reynolds NP, Lashuel HA*, Mezzenga R. (2015). Microtubule-Binding R3 Fragment from Tau Self-Assembles into Giant Multistranded Amyloid Ribbons. Angew Chem Int Ed Engl. 11;55(2):618-22.
Vasiliki P Chini (2015). Micro-RNAs and Next Generation Sequencing: New Perspectives in Heart Failure. Clin Chim Acta, Mar 30; 443:114-9.
Kolatkar PR, Moovarkumudalvan B, Abdelalim EM and Emara MM. (2016). Three dimensional Structure of SOX Protein–DNA Complexes. Sox2: Biology and Role in Development and Disease. 2016 ELSEVIER. P 15-24.
Balbekova A, Lohninger H, van Tilborg GAF, Dijkhuizen RM, Bonta M, Limbeck A, Lendl B, Al-Saad KA, Ali M, Celikic M, Ofner J. (2017). Fourier Transform Infrared (FT-IR) and Laser Ablation Inductively Coupled Plasma–Mass Spectrometry (LA-ICP-MS) Imaging of Cerebral Ischemia: Combined Analysis of Rat Brain Thin Cuts Toward Improved Tissue Classification. Appl Spectrosc. 2018 Feb;72(2):241-250. doi: 10.1177/0003702817734618.
Abdelalim EM and Emara MM. (2017). Pluripotent stem cell-derived pancreatic beta cells: from In vitro maturation to clinical applications. Recent Advances in Stem Cells: From Basic Research to Clinical Applications, ISBN 978-319-33270-3, pp 101-129, Springer.
As part of its extensive, month-long Autism Awareness Campaign, QBRI participated in various events across Doha, to shed light on the importance of early detection of autism spectrum disorder (ASD) ...
Cerebrospinal and serum alpha-synuclein species as potential biomarkers for Parkinson’s disease
The Qatar Metabolic Institute is very pleased to present the 1st Annual Qatar Metabolic Institute Conference. The conference, co-organized by Hamad Medical Corporation (HMC) and Qatar Biomedical ...
Qatar Foundation Research and Development’s flagship conference, builds upon nationwide efforts to advance Qatar's ambitious research agenda, and provides a unique platform to activate ...